Manuja Kaluarachchi1, Claire L Boulangé1, Ibrahim Karaman2, John C Lindon1,3, Timothy M D Ebbels3, Paul Elliott2,4, Russell P Tracy5,6, Nels C Olson7. 1. Metabometrix Ltd, Sir Alexander Fleming Building, Prince Consort Road, London, SW7 1BP, UK. 2. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, W2 1PG, UK. 3. Computational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London, SW7 2AZ, UK. 4. MRC-PHE Centre for Environment and Health, Imperial College London, London, W2 1PG, UK. 5. Department of Biochemistry, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05446, USA. 6. Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05446, USA. 7. Department of Pathology and Laboratory Medicine, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05446, USA. Nels.Olson@med.uvm.edu.
Abstract
INTRODUCTION: Differences in the metabolite profiles between serum and plasma are incompletely understood. OBJECTIVES: To evaluate metabolic profile differences between serum and plasma and among plasma sample subtypes. METHODS: We analyzed serum, platelet rich plasma (PRP), platelet poor plasma (PPP), and platelet free plasma (PFP), collected from 8 non-fasting apparently healthy women, using untargeted standard 1D and CPMG 1H NMR and reverse phase and hydrophilic (HILIC) UPLC-MS. Differences between metabolic profiles were evaluated using validated principal component and orthogonal partial least squares discriminant analysis. RESULTS: Explorative analysis showed the main source of variation among samples was due to inter-individual differences with no grouping by sample type. After correcting for inter-individual differences, lipoproteins, lipids in VLDL/LDL, lactate, glutamine, and glucose were found to discriminate serum from plasma in NMR analyses. In UPLC-MS analyses, lysophosphatidylethanolamine (lysoPE)(18:0) and lysophosphatidic acid(20:0) were higher in serum, and phosphatidylcholines (PC)(16:1/18:2, 20:3/18:0, O-20:0/22:4), lysoPC(16:0), PE(O-18:2/20:4), sphingomyelin(18:0/22:0), and linoleic acid were lower. In plasma subtype analyses, isoleucine, leucine, valine, phenylalanine, glutamate, and pyruvate were higher among PRP samples compared with PPP and PFP by NMR while lipids in VLDL/LDL, citrate, and glutamine were lower. By UPLC-MS, PE(18:0/18:2) and PC(P-16:0/20:4) were higher in PRP compared with PFP samples. CONCLUSIONS: Correction for inter-individual variation was required to detect metabolite differences between serum and plasma. Our results suggest the potential importance of inter-individual effects and sample type on the results from serum and plasma metabolic phenotyping studies.
INTRODUCTION: Differences in the metabolite profiles between serum and plasma are incompletely understood. OBJECTIVES: To evaluate metabolic profile differences between serum and plasma and among plasma sample subtypes. METHODS: We analyzed serum, platelet rich plasma (PRP), platelet poor plasma (PPP), and platelet free plasma (PFP), collected from 8 non-fasting apparently healthy women, using untargeted standard 1D and CPMG 1H NMR and reverse phase and hydrophilic (HILIC) UPLC-MS. Differences between metabolic profiles were evaluated using validated principal component and orthogonal partial least squares discriminant analysis. RESULTS: Explorative analysis showed the main source of variation among samples was due to inter-individual differences with no grouping by sample type. After correcting for inter-individual differences, lipoproteins, lipids in VLDL/LDL, lactate, glutamine, and glucose were found to discriminate serum from plasma in NMR analyses. In UPLC-MS analyses, lysophosphatidylethanolamine (lysoPE)(18:0) and lysophosphatidic acid(20:0) were higher in serum, and phosphatidylcholines (PC)(16:1/18:2, 20:3/18:0, O-20:0/22:4), lysoPC(16:0), PE(O-18:2/20:4), sphingomyelin(18:0/22:0), and linoleic acid were lower. In plasma subtype analyses, isoleucine, leucine, valine, phenylalanine, glutamate, and pyruvate were higher among PRP samples compared with PPP and PFP by NMR while lipids in VLDL/LDL, citrate, and glutamine were lower. By UPLC-MS, PE(18:0/18:2) and PC(P-16:0/20:4) were higher in PRP compared with PFP samples. CONCLUSIONS: Correction for inter-individual variation was required to detect metabolite differences between serum and plasma. Our results suggest the potential importance of inter-individual effects and sample type on the results from serum and plasma metabolic phenotyping studies.
Authors: Orla Teahan; Simon Gamble; Elaine Holmes; Jonathan Waxman; Jeremy K Nicholson; Charlotte Bevan; Hector C Keun Journal: Anal Chem Date: 2006-07-01 Impact factor: 6.986
Authors: P A Sakkinen; E M Macy; P W Callas; E S Cornell; T E Hayes; L H Kuller; R P Tracy Journal: Am J Epidemiol Date: 1999-02-01 Impact factor: 4.897
Authors: Renate B Schnabel; Jens Baumert; Maja Barbalic; Josée Dupuis; Patrick T Ellinor; Peter Durda; Abbas Dehghan; Joshua C Bis; Thomas Illig; Alanna C Morrison; Nancy S Jenny; John F Keaney; Christian Gieger; Cathy Tilley; Jennifer F Yamamoto; Natalie Khuseyinova; Gerardo Heiss; Margaret Doyle; Stefan Blankenberg; Christian Herder; Jeremy D Walston; Yanyan Zhu; Ramachandran S Vasan; Norman Klopp; Eric Boerwinkle; Martin G Larson; Bruce M Psaty; Annette Peters; Christie M Ballantyne; Jacqueline C M Witteman; Ron C Hoogeveen; Emelia J Benjamin; Wolfgang Koenig; Russell P Tracy Journal: Blood Date: 2009-12-29 Impact factor: 22.113
Authors: Lloyd W Sumner; Alexander Amberg; Dave Barrett; Michael H Beale; Richard Beger; Clare A Daykin; Teresa W-M Fan; Oliver Fiehn; Royston Goodacre; Julian L Griffin; Thomas Hankemeier; Nigel Hardy; James Harnly; Richard Higashi; Joachim Kopka; Andrew N Lane; John C Lindon; Philip Marriott; Andrew W Nicholls; Michael D Reily; John J Thaden; Mark R Viant Journal: Metabolomics Date: 2007-09 Impact factor: 4.290
Authors: Patrycja Mojsak; Katarzyna Maliszewska; Paulina Klimaszewska; Katarzyna Miniewska; Joanna Godzien; Julia Sieminska; Adam Kretowski; Michal Ciborowski Journal: Front Mol Biosci Date: 2022-09-23
Authors: Julie A Schmidt; Georgina K Fensom; Sabina Rinaldi; Augustin Scalbert; Marc J Gunter; Michael V Holmes; Timothy J Key; Ruth C Travis Journal: Metabolites Date: 2021-02-20